Cargando…
The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy
The Ketogenic Diet (KD) is a high-fat, low-carbohydrate diet that has been utilized as the first line treatment for contrasting intractable epilepsy. It is responsible for the presence of ketone bodies in blood, whose neuroprotective effect has been widely shown in recent years but remains unclear....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763157/ https://www.ncbi.nlm.nih.gov/pubmed/33321705 http://dx.doi.org/10.3390/metabo10120504 |
_version_ | 1783627951090171904 |
---|---|
author | Napolitano, Antonio Longo, Daniela Lucignani, Martina Pasquini, Luca Rossi-Espagnet, Maria Camilla Lucignani, Giulia Maiorana, Arianna Elia, Domenica De Liso, Paola Dionisi-Vici, Carlo Cusmai, Raffaella |
author_facet | Napolitano, Antonio Longo, Daniela Lucignani, Martina Pasquini, Luca Rossi-Espagnet, Maria Camilla Lucignani, Giulia Maiorana, Arianna Elia, Domenica De Liso, Paola Dionisi-Vici, Carlo Cusmai, Raffaella |
author_sort | Napolitano, Antonio |
collection | PubMed |
description | The Ketogenic Diet (KD) is a high-fat, low-carbohydrate diet that has been utilized as the first line treatment for contrasting intractable epilepsy. It is responsible for the presence of ketone bodies in blood, whose neuroprotective effect has been widely shown in recent years but remains unclear. Since glutathione (GSH) is implicated in oxidation-reduction reactions, our aim was to monitor the effects of KD on GSH brain levels by means of magnetic resonance spectroscopy (MRS). MRS was acquired from 16 KD patients and seven age-matched Healthy Controls (HC). We estimated metabolite concentrations with linear combination model (LCModel), assessing differences between KD and HC with t-test. Pearson was used to investigate GHS correlations with blood serum 3-B-Hydroxybutyrate (3HB) concentrations and with number of weekly epileptic seizures. The results have shown higher levels of brain GSH for KD patients (2.5 ± 0.5 mM) compared to HC (2.0 ± 0.5 mM). Both blood serum 3HB and number of seizures did not correlate with GSH concentration. The present study showed a significant increase in GSH in the brain of epileptic children treated with KD, reproducing for the first time in humans what was previously observed in animal studies. Our results may suggest a pivotal role of GSH in the antioxidant neuroprotective effect of KD in the human brain. |
format | Online Article Text |
id | pubmed-7763157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77631572020-12-27 The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy Napolitano, Antonio Longo, Daniela Lucignani, Martina Pasquini, Luca Rossi-Espagnet, Maria Camilla Lucignani, Giulia Maiorana, Arianna Elia, Domenica De Liso, Paola Dionisi-Vici, Carlo Cusmai, Raffaella Metabolites Article The Ketogenic Diet (KD) is a high-fat, low-carbohydrate diet that has been utilized as the first line treatment for contrasting intractable epilepsy. It is responsible for the presence of ketone bodies in blood, whose neuroprotective effect has been widely shown in recent years but remains unclear. Since glutathione (GSH) is implicated in oxidation-reduction reactions, our aim was to monitor the effects of KD on GSH brain levels by means of magnetic resonance spectroscopy (MRS). MRS was acquired from 16 KD patients and seven age-matched Healthy Controls (HC). We estimated metabolite concentrations with linear combination model (LCModel), assessing differences between KD and HC with t-test. Pearson was used to investigate GHS correlations with blood serum 3-B-Hydroxybutyrate (3HB) concentrations and with number of weekly epileptic seizures. The results have shown higher levels of brain GSH for KD patients (2.5 ± 0.5 mM) compared to HC (2.0 ± 0.5 mM). Both blood serum 3HB and number of seizures did not correlate with GSH concentration. The present study showed a significant increase in GSH in the brain of epileptic children treated with KD, reproducing for the first time in humans what was previously observed in animal studies. Our results may suggest a pivotal role of GSH in the antioxidant neuroprotective effect of KD in the human brain. MDPI 2020-12-10 /pmc/articles/PMC7763157/ /pubmed/33321705 http://dx.doi.org/10.3390/metabo10120504 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Napolitano, Antonio Longo, Daniela Lucignani, Martina Pasquini, Luca Rossi-Espagnet, Maria Camilla Lucignani, Giulia Maiorana, Arianna Elia, Domenica De Liso, Paola Dionisi-Vici, Carlo Cusmai, Raffaella The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy |
title | The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy |
title_full | The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy |
title_fullStr | The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy |
title_full_unstemmed | The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy |
title_short | The Ketogenic Diet Increases In Vivo Glutathione Levels in Patients with Epilepsy |
title_sort | ketogenic diet increases in vivo glutathione levels in patients with epilepsy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763157/ https://www.ncbi.nlm.nih.gov/pubmed/33321705 http://dx.doi.org/10.3390/metabo10120504 |
work_keys_str_mv | AT napolitanoantonio theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT longodaniela theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT lucignanimartina theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT pasquiniluca theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT rossiespagnetmariacamilla theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT lucignanigiulia theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT maioranaarianna theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT eliadomenica theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT delisopaola theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT dionisivicicarlo theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT cusmairaffaella theketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT napolitanoantonio ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT longodaniela ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT lucignanimartina ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT pasquiniluca ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT rossiespagnetmariacamilla ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT lucignanigiulia ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT maioranaarianna ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT eliadomenica ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT delisopaola ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT dionisivicicarlo ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy AT cusmairaffaella ketogenicdietincreasesinvivoglutathionelevelsinpatientswithepilepsy |